2Source: Centers for Disease Control and Prevention, http ://www. cdc. gov/ncidod/diseases/hepatitis/slideset/hep_b/hep_b, pdf.
3Locarnini SA. Hepatitis B virus surface antigen and polymerase gene variants: potential virological and clinical significance. Hepatology, 1998,27:294 -297.
4Jongerius JM, Wester M, Cuypers HT, et al. New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays. Transfusion, 1998 ,38:56-59.
5Seddigh-Tonekaboni S, Lim WL, Young B, et al. Hepatitis B surface antigen variants in vaccinees, blood donors and an interferon-treated patient.J Viral Hepat, 2001,8 : 154-158.
6Grethe S, Monazahian M, Bohme I, et al. Characterization of unusual escape variants of hepatitis B virus isolated from a hepatitis B surface antigennegative subject. J Virol, 1998,72:7692-7696.
7Book CT, Tillmann HL, Torresi J,et al. Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation. Gastroenterology,2002 , 122:264-273.
8Pult I, Chouard T, Wieland S, et al. A hepatitis B virus mutant with a new hepatceyte nuclear factor 1 binding site emerging in transplant-transmitted fulminant hepatitis B. Hepatology, 1997,25 : 1507-1515.
9Hunt CM, McGill JM, Allen MI, et al. Clinical relevance of hepatitis B viral mutations. Hepatology,2000,31 : 1037-1044.
10Oon C J, Lim GK, Ye Z, et al. Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine, 1995,13:699-702.
